Table 3. Relative Risk for Residual Axillary Nodal Metastases After NCT in Patients Without vs With Breast pCR.
Subgroup | RR (95% CI) | P Value |
---|---|---|
N0 | 14.0 (0.8-237.0) | .07 |
N1 | 5.3 (2.7-10.3) | <.001 |
HER2+ | 4.9 (2.0-11.9) | <.001 |
TN | 11.6 (3.7-36.0) | <.001 |
All | 7.4 (3.7-14.8) | <.001 |
Abbreviations: NCT, neoadjuvant chemotherapy; pCR, pathologic complete response; RR, relative risk; TN, triple-negative; +, positive.